Results

Total Results: 724 records

Showing results for "free".

  1. effectivehealthcare.ahrq.gov/products/cell-free-dna
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-key-question.pdf
    September 18, 2023 - Key Question Tumor Cell-free DNA for Cancer Screening 1 Key Question Tumor Cell-free DNA for Cancer … this technology for cancer screening.13 2 A report on the available evidence on tumor cell-free … Draft Key Question KQ1: What is the (a) efficacy and (b) safety of circulating tumor cell-free DNA screening … Population: Asymptomatic adults at average- or high-risk for cancer Intervention: Circulating tumor cell-free
  3. effectivehealthcare.ahrq.gov/products/form/cell-free-dna
  4. effectivehealthcare.ahrq.gov/health-topics/amyloidosis
    May 02, 2011 - Serum-Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias … Research Protocol Archived May 2, 2011 Serum Free Light Chain Analysis for the … Dyscrasias: Future Research Needs Systematic Review Archived September 19, 2012 Serum Free
  5. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/serum-free-light-chain-analysis-for-the-diagnosis
    June 17, 2009 - Serum free light chain analysis for the diagnosis Serum Free Light Chain Analysis for the Diagnosis
  6. effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research-protocol
    May 02, 2011 - Research Protocol Aug. 23, 2012 Systematic Review Jun. 28, 2013 Disposition of Comments Report Serum-Free … NSMM]). 1 In two-thirds of patients with NSMM, a monoclonal protein can be identified by the serum-free … Serum free light chain measurements move to center stage. Clin Chem 2005; 51: 805-7. … Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. … Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains
  7. effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay
    May 02, 2011 - Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias … Topic Initiated May 02, 2011 Research Protocol Archived Serum-Free … Cell Dyscrasias August 23, 2012 Systematic Review Archived Serum Free
  8. effectivehealthcare.ahrq.gov/health-topics/immune-system-and-disorders
    July 16, 2013 - and Above Living with HIV/AIDS Research Protocol Archived March 3, 2016 Serum-Free … Prognosis of Plasma Cell Dyscrasias Research Protocol Archived May 2, 2011 Serum Free … Dyscrasias: Future Research Needs Systematic Review Archived September 19, 2012 Serum Free
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-key-questions.pdf
    January 01, 2018 - survival  Colostomy-free survival (KQ1, KQ3, KQ5)  Local control  Pathologic complete response … Fractionation schemes Outcomes Overall survival Disease-free survival Colostomy-free survival Local … Other dose de-escalation Outcomes Overall survival Disease-free survival Colostomy-free survival … response Salvage rate Sphincter preservation Acute and late toxicity Overall survival Disease-free … survival Colostomy-free survival Local control Pathologic complete response Salvage rate Sphincter
  10. effectivehealthcare.ahrq.gov/health-topics/c%C3%A1ncer-0
    December 08, 2017 - Trials Evaluating Treatment for Infertility Research Report June 28, 2017 Serum-Free … Prognosis of Plasma Cell Dyscrasias Research Protocol Archived May 2, 2011 Serum Free
  11. effectivehealthcare.ahrq.gov/products/survival-quality
    April 12, 2013 - Progression-Free Survival: What Does it Mean for Psychological Well-being or Quality of Life? … Topic Initiated April 12, 2013 Research Report Progression-Free
  12. effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay-future
    September 19, 2012 - Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias … Initiated September 19, 2012 Systematic Review Archived Serum Free
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
    May 02, 2011 - myeloma Nonsecretory myeloma Smoldering multiple myeloma  Malignant plasma cells produce free … The normal plasma-cell production of free light chains is from 0.5 to 1.0 g/day.5 The detection of free … Serum free light chain measurements move to center stage. Clin Chem 2005; 51: 805-7. 5. … Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. … Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light
  14. effectivehealthcare.ahrq.gov/news/srdr-plus-launch
    This new version, called SRDR+ , is a free, powerful, online, collaborative system for extracting and … SRDR+ features major upgrades for: Researchers  as a free platform for extracting, archiving, and sharing
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
    September 01, 2012 - Serum free light chains for monitoring multiple myeloma. … Serum free light chains for monitoring multiple myeloma. … Serum free light chain measurements move to center stage. … Appraisal of immunoglobulin free light chain as a marker of response. … of the serum free light chain response definitions.
  16. effectivehealthcare.ahrq.gov/products/survival-quality/research
    April 12, 2013 - Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? … Structured Abstract Background Progression-free survival (PFS), defined as the time from random assignment … The four studies demonstrated better QOL or disease symptoms among patients who remained progression-free … association with OS; and (3) the extent to which improvement in QOL measures associated with progression-free
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
    April 01, 2013 - Methods Research Report - Progression-Free Survival: What Does It Mean for Psychological Well-Being or … Ideally, studies would be free from bias. … Issues in using progression-free survival when evaluating oncology products. … The value of progression-free survival to patients with advanced-stage cancer. … OR "progression free survival" OR "progression-free survival" OR "time to progression" AND (("Quality
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/search-strategies_research.pdf
    June 01, 2012 - Of the 25 peer reviewers invited to participate, 24 completed the initial free-form round of reviews … , and 15 completed either the PRESS review or a second free-form review as part of our control group … Free-form Review Form Appendix C. PRESS Review Form Appendix D. … Objective 3: Compare PRESS instrument to free form evaluations. … Free-Form Review Form Appendix C. PRESS Review Form Appendix D.
  19. effectivehealthcare.ahrq.gov/health-topics/vascular-diseases
    August 16, 2010 - on Chronic Disease Outcomes and Risks Systematic Review June 21, 2018 Serum-Free … Prognosis of Plasma Cell Dyscrasias Research Protocol Archived May 2, 2011 Serum Free … Dyscrasias: Future Research Needs Systematic Review Archived September 19, 2012 Serum Free
  20. effectivehealthcare.ahrq.gov/products/search-strategies/research
    June 07, 2012 - Specific Aims : Evaluate whether the PRESS instrument or no-instrument (‘free-form’ evaluations) is … Each TEPR was assigned to either the control group who only wrote “free-form” reviews or to the group … who initially wrote a “free-form” review, then trained using the PRESS Instrument, and finally completed … Of the 25 peer reviewers invited to participate, 24 completed the initial free-form round of reviews, … and 15 completed either the PRESS review or a second free-form review as part of our control group.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: